Initiating or changing to a fixed-dose combination of Fluticasone propionate/Formoterol over Fluticasone propionate/Salmeterol: A real-life effectiveness and cost impact evaluation
Author:
Funder
NAPP Pharmaceutical Group Ltd
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference42 articles.
1. Asthma;Martinez;Lancet,2013
2. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015;Disease;Lancet,2016
3. Evaluation of asthma control by physicians and patients: comparison with current guidelines;Boulet;Can. Respir. J.,2002
4. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys;Rabe;J. Allergy Clin. Immunol.,2004
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Budesonide/Glycopyrrolate/Formoterol for the Management of COPD in a UK Primary Care Population: Real-World Use and Early Medication Success;International Journal of Chronic Obstructive Pulmonary Disease;2024-05
2. Fixed-dose combination fluticasone/formoterol for asthma treatment in a real-world setting: meta-analysis of exacerbation rates and asthma control;European Clinical Respiratory Journal;2023-01
3. A review of the efficacy and safety of fluticasone propionate/formoterol fixed-dose combination;Expert Review of Respiratory Medicine;2022-05-04
4. Fluticasone/formoterol compared with other ICS/LABAs in asthma: a systematic review;Journal of Asthma;2021-03-25
5. An Indian perspective on the use of fluticasone/formoterol in asthma and chronic obstructive pulmonary disease patients;Indian Journal of Respiratory Care;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3